financetom
Business
financetom
/
Business
/
Louisiana-Pacific Insider Sold Shares Worth $3,779,369, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Louisiana-Pacific Insider Sold Shares Worth $3,779,369, According to a Recent SEC Filing
Mar 10, 2026 10:46 PM

02:09 PM EST, 12/17/2025 (MT Newswires) -- William Bradley Southern, Director, Chief Executive Officer, on December 15, 2025, sold 43,832 shares in Louisiana-Pacific ( LPX ) for $3,779,369. Following the Form 4 filing with the SEC, Southern has control over a total of 558,590 common shares of the company, with 558,590 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/60519/000119312525322396/xslF345X05/ownership.xml

Price: 83.94, Change: -0.50, Percent Change: -0.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Colliers Acquiring Canadian Engineering Firm Englobe; National Bank Dubs Deal a 'Positive Overture'
Update: Colliers Acquiring Canadian Engineering Firm Englobe; National Bank Dubs Deal a 'Positive Overture'
Jun 3, 2024
10:53 AM EDT, 06/03/2024 (MT Newswires) -- Global diversified professional services and investment management company, Colliers on Monday entered into a definitive agreement to acquire Englobe Corporation, a Canadian multi-discipline engineering, environmental and inspection services firm. A statement noted Englobe's senior leadership team and employee shareholders will remain shareholders in the business under Colliers' partnership model. In 2023, the statement...
CNS Pharmaceuticals Schedules 1-For-50 Reverse Stock Split This Week
CNS Pharmaceuticals Schedules 1-For-50 Reverse Stock Split This Week
Jun 3, 2024
10:54 AM EDT, 06/03/2024 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) was falling hard in Monday trading, losing about one-third of its prior value, after the biopharmaceutical company plans a 1-for-50 reverse split of its common stock one minute following the close of Tuesday's regular trading session. The stock will trade on a split-adjusted basis starting Wednesday. The company...
Why CNS Pharmaceuticals Shares Are Getting Hammered
Why CNS Pharmaceuticals Shares Are Getting Hammered
Jun 3, 2024
CNS Pharmaceuticals, Inc ( CNSP ) shares are trading lower by 33.4% to $0.14 during Monday’s session after the company announced a 1-for-50 reverse split of its common stock, effective at 4:01 PM ET on June 4. This move aims to increase the share price and meet Nasdaq’s minimum share price requirement. In the reverse split, every 50 shares of...
Cadence Design Systems Acquires BETA CAE Systems
Cadence Design Systems Acquires BETA CAE Systems
Jun 3, 2024
10:56 AM EDT, 06/03/2024 (MT Newswires) -- Cadence Design Systems ( CDNS ) said Monday it has completed the acquisition of BETA CAE Systems International, an engineering simulation solutions provider. BETA CAE enhances the company's intelligence system design strategy with the expansion of its multiphysics system analysis suite, Cadence said. The company still anticipates the deal to be roughly $0.12...
Copyright 2023-2026 - www.financetom.com All Rights Reserved